Mobile

A Single Arm Phase II Study to assess the efficacy of intensified intravenous Melphalan in combination with a transplant of the patient's own blood stem cells for a maximum of three cycles in patients...

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-000351-14

A Single Arm Phase II Study to assess the efficacy of intensified intravenous Melphalan in combination with a transplant of the patient's own blood stem cells for a maximum of three cycles in patients with castration-resistant prostate cancer (CRPC)

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To determine the efficacy of intensified intravenous melphalan with autologous whole blood stem cell transplantation in patients with Castration-resistant prostate cancer using Progression Free Survival rate

Critère d'inclusion

  • castration resistant prostate cancer patients

Liens